ConductScience.org, home

Paper · 34849009

Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer.

Zhang S and 5 others. Int J Gen Med, 2021. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer. Papers, record 34849009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34849009

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer.
PubMed
Journal
Int J Gen Med
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.31
iCite
Revised in PubMed
2022-04-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang SShun
2Wang CCheng
3Xia WWeimin
4Duan HHuangqi
5Qian SSubohttps://orcid.org/0000-0001-6097-6484
6Shen HHaibohttps://orcid.org/0000-0002-1183-6570

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124,309,898Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.Mol Cell Proteomics2014https://conductscience.org/library/papers/24309898PubMed
230,925,886Ferroptosis, a new form of cell death: opportunities and challenges in cancer.J Hematol Oncol2019https://conductscience.org/library/papers/30925886PubMed
334,386,423A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.Front Oncol2021https://conductscience.org/library/papers/34386423PubMed
433,538,338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
529,383,104CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway.Oncotarget2017https://conductscience.org/library/papers/29383104PubMed
612,676,586Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells.Cancer Cell2003https://conductscience.org/library/papers/12676586PubMed
734,557,413Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.Front Oncol2021https://conductscience.org/library/papers/34557413PubMed
828,985,560Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.Cell2017https://conductscience.org/library/papers/28985560PubMed
931,207,603TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.Nature2019https://conductscience.org/library/papers/31207603PubMed
1028,813,679The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity.Cell Rep2017https://conductscience.org/library/papers/28813679PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42,493,447[Development of a 36-gene signature for predicting recurrence in non-muscle-invasive bladder cancer and validation in a Chinese cohort].Beijing Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42493447PubMed
40,815,405A nomogram integrating mutation signatures and clinical features for prognostic stratification in bladder cancer.Discov Oncol2025https://conductscience.org/library/papers/40815405PubMed
39,833,962Methyltransferase-like 7B participates in bladder cancer via ACSL3 m6A modification in a ferroptosis manner.Biol Direct2025https://conductscience.org/library/papers/39833962PubMed
39,466,353Development of a Novel Risk Signature for Predicting the Prognosis and Immunotherapeutic Response of Prostate Cancer by Integrating Ferroptosis and Immune-Related Genes.Mol Biotechnol2025https://conductscience.org/library/papers/39466353PubMed
37,886,960Ferroptosis: An Emerging Target for Bladder Cancer Therapy.Curr Issues Mol Biol2023https://conductscience.org/library/papers/37886960PubMed
36,213,323Downregulated PRNP Facilitates Cell Proliferation and Invasion and Has Effect on the Immune Regulation in Ovarian Cancer.J Immunol Res2022https://conductscience.org/library/papers/36213323PubMed

Genes36

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34849009

GET https://conductscience.org/api/papers/v1/34849009/references?page=2